You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:三大指數齊跌,恒指跌0.15%,創新藥逆市活躍
格隆匯 07-29 16:30

港股三大指數午後持續回升跌幅明顯縮窄,恒生指數、國企指數分別下跌0.15%及0.34%,二者盤中均跌至1.2%,恒生科技指數盤中更是大跌2%,最終收跌0.35%。值得注意的是,在指數調整之際,南下資金大幅淨買入港股超100億港元。

盤面上,午後大型科技股跌幅收窄,尤其是阿里巴巴小幅轉升,騰訊、京東、美團、快手跌幅在1%以內,小米走勢較弱仍下跌2.6%;生物醫藥股全天表現強勢行情,創新藥方向升幅搶眼,其中,藥明康德大升超11%,石藥集團、綠葉製藥升超8%;“反內卷”相部分板塊午後回升明顯,以鋼鐵股、光伏股等為首由跌轉升,石油股、濠賭股、半導體芯片股多數上升。另一方面,3600元生育補貼落地,三胎概念股呈現高開低走行情,內銀股全天表現低迷,工商銀行、建設銀行、農業銀行均走低,餐飲股、機器人概念股普遍下跌。

具體來看:

內銀股震盪走低,重慶農村商業銀行、中國光大銀行、貴州銀行、青島銀行跌超3%,民生銀行、中原銀行、中信銀行跌超2%。

三胎概念高開低走,好孩子國際跌超7%,錦欣生殖跌超4%,H&H國際控股、中國旺旺跟跌。

消息面上,昨日國家育兒補貼制度實施方案公佈,從2025年1月1日起,無論一孩、二孩、三孩,每年均可領取3600元補貼,直至年滿3週歲。此次育兒補貼政策實現了全面覆蓋,地方補充政策仍值得期待,以3月呼市政策為例,生育補貼力度更大。

餐飲股跌幅居前,富臨集團控股跌超7%,百福控股跌超6%,新享時代跌超5%,達勢股份、小菜園等跟跌。

生物科技股大升,藥明巨諾-B升超33%,創勝集團-B升超17%,東曜藥業-B升超15%,和譽-B、藥明康德、泰格醫藥等跟升。

消息面上,藥明康德昨晚公佈,2025年上半年業績表現亮眼,營業收入208億元,同比增長20.64%,歸屬淨利潤同比大升101.92%。公司預計2025年持續經營業務收入重回雙位數增長,增速從10-15%上調至13-17%,全年整體收入從人民幣415-430億元上調至人民幣425-435億元。

汽車經銷商股逆勢拉昇,冠轈控股升超9%,中升控股升超6%,永達汽車、和諧汽車等跟升。

消息上,瑞銀日前發表研究報吿指,中升控股及永達汽車近期股價分別反彈,相信是來自於中國當局“反內卷”政策,市場憧憬新車銷售利潤率改善;一些經銷商結業的新聞令市場揣測行業未來迎來整合;以及投資者趁低吸納較低估值股份。憧憬若政策有效遏制行業價格戰,瑞銀相信經銷商盈利能力或顯著改善。

鋼鐵股震盪走高,馬鞍山鋼鐵升超8%,綠色經濟、鞍鋼股份升超5%,亞太資源升超4%,重慶鋼鐵股份、中國東方集團等跟升。

蘋果概念表現活躍,瑞聲科技升超3%,高偉電子、偉仕佳傑升超2%,通達集團、舜宇光學科技、比亞迪電子等跟升。

消息面上,蘋果中國官網顯示,Apple Store大連百年城店將於2025年8月9日20:00停止營業,為中國首家關停的直營店,蘋果暫未表示關店原因。

今日,南向資金淨買入127.2億港元,其中,港股通(滬)淨買入58.78億港元,港股通(深)淨買入68.42億港元。

展望後市,華泰證券研報表示,往後看,依然看好港股市場機會,恒生科技修復空間或更大。具體細分板塊上,建議優選景氣改善+低估值行業。1)互聯網方向,如電商、本地生活等細分板塊景氣有築底態勢,估值較為合理;遊戲景氣度較高,估值或具有一定性價比;2)煤炭、水泥及週期品景氣度或因“反內卷”提速而加速築底;3)社會服務、紡織服裝、航空機場等正處於估值不高+高景氣的階段;4)港股新消費景氣度仍高,但需關注在估值相對高位下的三季度解禁壓力。華泰證券強調關注港股科技板塊,其正處於景氣修復+估值低位交集,也是內外資的共識,且大多為大市值頭部公司,更適合機構投資者“高切低”佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account